UE vs. GSK
Compare and contrast key facts about Urban Edge Properties (UE) and GlaxoSmithKline plc (GSK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: UE or GSK.
Correlation
The correlation between UE and GSK is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
UE vs. GSK - Performance Comparison
Key characteristics
UE:
1.29
GSK:
-0.31
UE:
1.83
GSK:
-0.30
UE:
1.23
GSK:
0.96
UE:
0.94
GSK:
-0.26
UE:
4.89
GSK:
-0.51
UE:
5.34%
GSK:
14.67%
UE:
20.27%
GSK:
23.98%
UE:
-71.78%
GSK:
-55.21%
UE:
-7.73%
GSK:
-18.49%
Fundamentals
UE:
$2.77B
GSK:
$74.11B
UE:
$2.23
GSK:
$1.54
UE:
9.17
GSK:
23.42
UE:
6.59
GSK:
0.82
UE:
$328.60M
GSK:
$23.26B
UE:
$134.77M
GSK:
$16.84B
UE:
$180.18M
GSK:
$6.82B
Returns By Period
In the year-to-date period, UE achieves a 0.51% return, which is significantly lower than GSK's 8.07% return. Over the past 10 years, UE has outperformed GSK with an annualized return of 2.70%, while GSK has yielded a comparatively lower 2.13% annualized return.
UE
0.51%
8.70%
9.59%
28.94%
7.33%
2.70%
GSK
8.07%
13.93%
-9.86%
-9.11%
0.56%
2.13%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
UE vs. GSK — Risk-Adjusted Performance Rank
UE
GSK
UE vs. GSK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Urban Edge Properties (UE) and GlaxoSmithKline plc (GSK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
UE vs. GSK - Dividend Comparison
UE's dividend yield for the trailing twelve months is around 3.15%, less than GSK's 4.26% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
UE Urban Edge Properties | 3.15% | 3.16% | 3.50% | 4.54% | 3.16% | 5.26% | 4.59% | 5.29% | 3.45% | 2.98% | 3.41% | 0.00% |
GSK GlaxoSmithKline plc | 4.26% | 4.60% | 3.75% | 4.78% | 4.92% | 5.49% | 4.28% | 5.55% | 5.72% | 7.06% | 5.96% | 6.09% |
Drawdowns
UE vs. GSK - Drawdown Comparison
The maximum UE drawdown since its inception was -71.78%, which is greater than GSK's maximum drawdown of -55.21%. Use the drawdown chart below to compare losses from any high point for UE and GSK. For additional features, visit the drawdowns tool.
Volatility
UE vs. GSK - Volatility Comparison
The current volatility for Urban Edge Properties (UE) is 6.80%, while GlaxoSmithKline plc (GSK) has a volatility of 10.35%. This indicates that UE experiences smaller price fluctuations and is considered to be less risky than GSK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
UE vs. GSK - Financials Comparison
This section allows you to compare key financial metrics between Urban Edge Properties and GlaxoSmithKline plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities